Trial | NCT03963076  Report issue

Title

Efficacy of Nasal Spray Hypertonic Puressentiel on Symptoms of Allergic Rhinitis
Evaluation of the Efficiency of Nasal Spray Hypertonic Puressentiel on Symptoms of Patients With Allergic Rhinitis

  • Phase

    N/A

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    60
Prospective multicentric study.

60 subjects with allergic rhinitis will be enrolled to test the efficacy of nasal hypertonic spray Puressentiel on symptoms of allergic rhinitis and nasal peak flow.

Subjects with allergic rhinitis and nasal obstruction will use during 30 days the nasal spray (2 nebulisations /day in each nostril) during 30 days.

Rhinitis symptoms questionnaire and nasal inspiratory peak flow will be evaluated before and after 30 days of exposure.
Objective: evaluate the efficiency of a nasal hypertonic spray Puressentiel in subjects with allergic rhinitis and nasal obstruction.

Inclusion criteria: subjects with allergic obstructive rhinitis without treatment or remaining symptomatic despite treatment.

Duration of exposure: 2 nasal sprays per day (morning and evening) during 30 months.

Primary criteria of efficacy: Rhinitis questionnaire.

Secondary criteria: Inspiratory nasal peak flow
Study Started
May 01
2019
Primary Completion
Sep 30
2019
Anticipated
Study Completion
Oct 31
2019
Anticipated
Last Update
May 24
2019

allergic rhinitis Experimental

administration of a nasal hypertonic spray twice a day for one month

Criteria 

Inclusion Criteria:

allergic rhinitis with nasal obstruction

Exclusion Criteria:

pregnant patients
patients with severe asthma
No Results Posted